The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts
Authors
Keywords
SF3B1, U2AF1, SRSF2, MDS without RS
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-06-26
DOI
10.1186/s12885-015-1493-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myelodysplastic Syndromes
- (2017) Peter L. Greenberg et al. Journal of the National Comprehensive Cancer Network
- Mutational analysis of splicing machinery genesSF3B1, U2AF1andSRSF2in myelodysplasia and other common tumors
- (2013) Eun Mi Je et al. INTERNATIONAL JOURNAL OF CANCER
- Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
- (2012) F. Damm et al. BLOOD
- Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
- (2012) F. Thol et al. BLOOD
- The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
- (2012) S.-J. Wu et al. BLOOD
- Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
- (2012) H. Makishima et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Myeloid malignancies: mutations, models and management
- (2012) Anne Murati et al. BMC CANCER
- Defects in spliceosomal machinery: a new pathway of leukaemogenesis
- (2012) Jaroslaw P. Maciejewski et al. BRITISH JOURNAL OF HAEMATOLOGY
- Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders
- (2012) V Visconte et al. LEUKEMIA
- New connections between splicing and human disease
- (2012) Richard A. Padgett TRENDS IN GENETICS
- Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
- (2011) L. Malcovati et al. BLOOD
- The Spliceosome as an Indicted Conspirator in Myeloid Malignancies
- (2011) Omar Abdel-Wahab et al. CANCER CELL
- SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications
- (2011) F Damm et al. LEUKEMIA
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
- (2011) Timothy A Graubert et al. NATURE GENETICS
- Spliceosome mutations in hematopoietic malignancies
- (2011) Christopher N Hahn et al. NATURE GENETICS
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
- (2011) E. Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytogenetic characteristics and prognosis analysis in 231 myelodysplastic syndrome patients from a single institution
- (2010) Seung-Won Jung et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now